Badrilla

Badrilla is a biological reagents company with a focus on providing assays and reagents for biomarker detection, phosphorylation, and S-palmitoylation. Founded in 2003, the company offers well-validated research antibodies for cardiac proteins, chemistry kits for the study of S-palmitoylation, and standards for precise and accurate quantification of immunoassay data. Badrilla also collaborates with researchers to develop new probes for emerging areas of research. Emphasizing prompt and thorough characterisation, the company aims to make these probes available to the broader scientific community. Badrilla operates within the Biopharma, Biotechnology, Health Care, and Clean Energy industries. While specific information about the company's headquarters and recent investments is not available, the company's commitment to providing essential reagents for cutting-edge research positions it as an intriguing potential investment opportunity for venture capital firms.